Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1987-12-23
|
pubmed:abstractText |
Immunosuppression is a well-characterized consequence of chronic graft-versus-host disease (GVHD). We have previously shown that interferon (IFN) is produced in high levels during acute GVHD. Our objective in this study was to determine if IFN, as a cytokine with known immunosuppressive qualities, could be detected in mice experiencing chronic GVHD-induced immunosuppression. Two different experimental models were used to induce chronic GVHD. The first model involved the injection of parental strain spleen cells into adult F1 hybrids (AJ----B6AF1), while the second model utilized GVHD induced across minor histocompatibility barriers (B10.D2----BALB/c). Results indicated that significant levels of serum IFN-alpha/beta are present in mice undergoing chronic GVHD. Spleen cells from chronic GVHD mice were also shown to produce significant levels of IFN-alpha/beta upon in vitro culture in medium only. This IFN-alpha/beta production was greatly increased when GVHD spleen cells were cultured with either concanavalin A (Con A) or IL-2. In contrast, IFN-gamma production was undetectable in these Con A- or IL-2-containing cultures. Additionally, these same spleen cells which produced high levels of IFN-alpha/beta were immunosuppressed as measured by mitogen-induced cell proliferation. These results suggest that IFN-gamma production is defective in GVHD spleen cells, and that the presence of high IFN-alpha/beta production by GVHD mice may contribute to the immunosuppression associated with chronic GVHD.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0008-8749
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
120-30
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:3119228-Acute Disease,
pubmed-meshheading:3119228-Animals,
pubmed-meshheading:3119228-Bone Marrow Transplantation,
pubmed-meshheading:3119228-Cells, Cultured,
pubmed-meshheading:3119228-Chronic Disease,
pubmed-meshheading:3119228-Concanavalin A,
pubmed-meshheading:3119228-Female,
pubmed-meshheading:3119228-Graft vs Host Disease,
pubmed-meshheading:3119228-Immune Tolerance,
pubmed-meshheading:3119228-Interferon Type I,
pubmed-meshheading:3119228-Interferon-gamma,
pubmed-meshheading:3119228-Interleukin-2,
pubmed-meshheading:3119228-Lymphocyte Activation,
pubmed-meshheading:3119228-Mice,
pubmed-meshheading:3119228-Mice, Inbred Strains,
pubmed-meshheading:3119228-Spleen
|
pubmed:year |
1987
|
pubmed:articleTitle |
Enhanced interferon-alpha/beta (IFN-alpha/beta) and defective IFN-gamma production in chronic graft versus host disease: a potential mechanism for immunosuppression.
|
pubmed:affiliation |
Department of Microbiology, University of Texas Medical Branch, Galveston 77550.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|